Alkermes plc - Ordinary Shares (ALKS): Price and Financial Metrics
ALKS Price/Volume Stats
| Current price | $24.07 | 52-week high | $33.71 |
| Prev. close | $23.85 | 52-week low | $22.01 |
| Day low | $23.76 | Volume | 1,708,200 |
| Day high | $24.19 | Avg. volume | 1,916,061 |
| 50-day MA | $27.67 | Dividend yield | N/A |
| 200-day MA | $27.65 | Market Cap | 4.07B |
ALKS Stock Price Chart Interactive Chart >
Alkermes plc - Ordinary Shares (ALKS) Company Bio
Alkermes plc is a fully integrated, global biopharmaceutical company developing innovative medicines for the treatment of central nervous system (CNS) diseases. The company has a diversified commercial product portfolio and a substantial clinical pipeline of product candidates for chronic diseases that include schizophrenia, depression, addiction and multiple sclerosis. The company was founded in 1987 and is based in Dublin, Ireland.
Latest ALKS News From Around the Web
Below are the latest news stories about ALKERMES PLC that investors may wish to consider to help them evaluate ALKS as an investment opportunity.
Equal Opportunity and Respect: Diversity, Inclusion and Belonging at AlkermesOriginally published in Alkermes September 2023 Corporate Responsibility Report NORTHAMPTON, MA / ACCESSWIRE / December 27, 2023 / Our employees are the foundation upon which our business is built. Their expertise, intelligence and creativity drive ... |
Alkermes (ALKS) Outperforms Broader Market: What You Need to KnowAlkermes (ALKS) reachead $27.92 at the closing of the latest trading day, reflecting a +1.34% change compared to its last close. |
The Cream Of The Crop: 5 Biotechs That Outrank Most StocksThe top five biotech stocks today have several commonalities. Among them are strong ratings. Some show promising charts and are Tech Leaders. |
11 Most Promising Psychedelic Stocks According to Hedge FundsIn this piece, we will take a look at the 11 most promising psychedelic stocks according to hedge funds. If you want to skip our overview of the psychedelic industry and the latest news, then you can take a look at the 5 Most Promising Psychedelic Stocks. The ability to use chemicals to alter one’s […] |
Corporate Governance at AlkermesNORTHAMPTON, MA / ACCESSWIRE / December 20, 2023 / Alkermes Originally published in Alkermes September 2023 Corporate Responsibility Report Board of Directors Our Board is currently comprised of eleven members, each of whom has a term expiring at ... |
ALKS Price Returns
| 1-mo | -11.80% |
| 3-mo | -14.40% |
| 6-mo | -2.55% |
| 1-year | -17.51% |
| 3-year | 13.11% |
| 5-year | -20.59% |
| YTD | -13.23% |
| 2023 | 6.16% |
| 2022 | 12.34% |
| 2021 | 16.59% |
| 2020 | -2.21% |
| 2019 | -30.87% |
Continue Researching ALKS
Want to see what other sources are saying about Alkermes plc's financials and stock price? Try the links below:Alkermes plc (ALKS) Stock Price | Nasdaq
Alkermes plc (ALKS) Stock Quote, History and News - Yahoo Finance
Alkermes plc (ALKS) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...